Last night, Sept. 12, the long-awaited Zen Diagram tour went off with a bang, bringing co-headline acts The War on Drugs and The National and featured guests Lucius to Gilford, N.H.’s Bank of ...

New research indicates that the heart benefits of semaglutide can extend to those with heart failure. In a recent analysis from the SELECT trial, researchers reported that semaglutide 2.4 mg ...

Cardiol Therapeutics Inc. President and CEO David Elsley discusses the rise in heart failure deaths among young adults on ...

Bayer AG’s kidney drug Kerendia helped patients avoid complications from a common form of heart failure in a study, a boost for the company’s pharma division as it looks to overcome multiple ...

Most people who undergo chemotherapy do not develop heart failure. However, specific chemotherapy drugs may significantly increase your risk of heart failure and other cardiac problems.

However, there were fears the drug might be harmful to those with a certain type of heart failure. Now a new study suggests that, within the group that had heart disease, semaglutide worked just ...

In order for the drug to get FDA approval for use in these people with heart failure, Bayer, the pharmaceutical company behind finerenone, would need to apply to the agency for an expanded indication.

Like other drugs for heart failure, SGLT2 inhibitors were originally developed to lower blood sugar levels in patients with diabetes. But this drug soon found its way into the heart of clinics that ...

The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...

Novo Nordisk’s obesity drug Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a new analysis that could boost the company’s efforts to ...